SCHEMBL4970607

SCHEMBL4970607

O=[N+]([O-])c1ccc(NC[CH]c2ncc(-c3cnc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)nc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.55
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 6/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 1/20 0.41
CDK1 P06493 2/20 0.40
GSK3A P49840 2/20 0.40
CCNB2 O95067 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
NPBWR1 P48145 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7022502 0.90 MEN1 (0.43) GSK3BMEN1KMT2ALMNAMAPT
SCHEMBL7850973 0.86 GSK3B (0.40) GSK3BMEN1KMT2ALMNAHTT
SCHEMBL7022779 0.86 GSK3B (0.73) GSK3BMEN1KMT2ALMNAKDM4E
SCHEMBL7852739 0.85 GSK3B (0.38) GSK3BMEN1KMT2ALMNAMAPT
SCHEMBL7022814 0.85 MAPT (0.39) GSK3BMEN1KMT2ALMNAHTT
SCHEMBL4393725 0.85 GSK3B (0.75) GSK3BMEN1KMT2ALMNAKDM4E
SCHEMBL4972797 0.84 GSK3B (0.47) GSK3BMEN1KMT2ALMNAKDM4E
SCHEMBL4970968 0.84 GSK3B (0.57) GSK3BMEN1KMT2ALMNAKDM4E
SCHEMBL7852234 0.84 GSK3B (0.51) GSK3BMEN1KMT2ALMNAKDM4E
SCHEMBL7854664 0.83 GSK3B (0.51) GSK3BMEN1KMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1653970-A4 GSK-3 INHIBITORS AND USES THEREOF NOVARTIS VACCINES & DIAGNOSTIC (US) 2008-10-15 EP disclosed
EP-1653970-A2 GSK-3 INHIBITORS AND USES THEREOF CHIRON CORPORATION (US) 2006-05-10 EP disclosed
WO-2005039485-A2 GSK-3 INHIBITORS AND USES THEREOF CHIRON CORPORATION (US) 2005-05-06 WO disclosed